Ariadne Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
1,003
-231
-19% -$236K 0.53% 46
2026
Q1
$1.14M Buy
1,234
+82
+7% +$83.1K 0.51% 41
2025
Q4
$1.2M Sell
1,152
-4
-0.3% -$3.83K 0.49% 44
2025
Q3
$1.18M Buy
1,156
+26
+2% +$19.3K 0.53% 45
2025
Q2
$746K Sell
1,130
-93
-8% -$72.3K 0.36% 61
2025
Q1
$899K Buy
1,223
+20
+2% +$16.6K 0.47% 55
2024
Q4
$1.05M Buy
1,203
+82
+7% +$67.9K 0.48% 51
2024
Q3
$894K Buy
+1,121
New +$1.01M 0.49% 42

Other funds holding LLY

Ariadne Wealth Management's LLY Position: Q2 2026 in Review

Ariadne Wealth Management reduced its Eli Lilly (LLY) stake by 19% in Q2 2026, selling an estimated $236K and leaving 1,003 shares worth $1.2M. The position accounts for 0.53% of the portfolio, ranked #46.

Ariadne Wealth Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ariadne Wealth Management held 1,003 shares of Eli Lilly worth $1.2M as of Q2 2026.
  • Ariadne Wealth Management sold 231 Eli Lilly shares in Q2 2026, an estimated $236K.
  • Eli Lilly made up 0.53% of Ariadne Wealth Management's portfolio in Q2 2026, its #46 holding.
  • Ariadne Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ariadne Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.